logo 03 logo 05 logo 07

R&D, Licensing



  Industrial Partnerships team

General inquiries


  R&D contracts (MAT, CDA,...)




What for?

Inserm Transfert's primary objective in licensing technology or signing R&D partnerships is to maximize the likelihood that technologies and know-how will reach the market in a timely fashion. We place great value on building strong public-private partnerships between biopharmaceutical companies and academic research teams/centres to accomplish this strategic goal.


What we do

We propose tailor-made solutions for each project to both partners: these could be R&D partnerships, licensing agreements, consulting agreements or even strategic alliances (see glossary below).


How do we do it?inserm 49236© Inserm / P.Latron

Whether contact with the partner is initiated by the Inserm Transfert team, by you or by the industry, a contract is required. Inserm Transfert will take responsibility for drafting, negociating, and implementing this contract.

In each case, negotiations will include your input (the academic team) and consideration of the needs of the prospective licensee or partner and the needs and policies of parent and sister institutions.





Don't forget!

Your research tools are valuable! Animal models, cell lines or monoclonal antibodies, etc. can be registered online on our Migratech database (see link). For assistance or more information, contact us: email.



An R&D partnership is a limited research and development partnership, usually between an academic research team and a healthcare company, set up to develop a specific project. In this type of agreement, the health industry company typically provides funding and the academic team carries out the R&D activities.


A licensing agreement is an agreement whereby Inserm Transfert grants a licence to use Inserm and other co-owners' intellectual property rights in the technology defined to a third party (established company or new business start-up). It may concern a particular field of use and/or region of the world and may be exclusive or non-exclusive.


A consulting agreement is an agreement between a company seeking scientific consulting and expertise and an independent consultant – in this case an academic scientist. The consulting relationship between the consultant and the outside entity is a personal agreement to which neither Inserm nor Inserm Transfert are party; nevertheless, it is governed by the scientist's obligations to Inserm regarding any intellectual property he/she may develop and conflicts of interest.


A strategic alliance is an agreement resulting primarily from proactive sourcing and scouting on the part of Inserm Transfert teams. It is typically a large-scale framework agreement that structures joint research projects over a limited period. These projects may consist of basic, translational and clinical research and technology development.

Increase font size Default font size Decrease font size